ESTA

Establishment Labs Holdings Inc. Health Care Orthopedic, Prosthetic & Surgical Appliances & Supplies Russell 3000
$62.46Close $1.8BMarket cap $47.80 – $95.6552-week range Late-januaryNext report · estimated

Highlights

Cautions

  • Not in an uptrend 2 of 8 trend conditions
  • Lagging the market RS 23 · weaker than 77% of stocks over 12 months
  • Far from its high 35% below its 52-week high

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 7, 2026
Off 12-month high 35%
1wk down 2.1% price change
1mo down 2.7% price change
12-month return up 23% market up 11% · its own up 9%
F-score 4 / 9 Weak
Altman Z 2.14 Moderate risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 77.7× price / book
Earnings yield down 1.9% EBIT / enterprise value
Cheaper than 12% of the market · expensive
Revenue growth up 27% year on year
EPS growth — latest quarter
Sales growth up 32% latest quarter · -13 pts
ROE down 133% return on equity
Free cash margin down 27% -$56.9M FCF
D/E 10.51 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • operating cash flow is negative
  • short-term liquidity weakened
  • issued more shares
  • assets working less efficiently
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • gross margin widened

Repair signals

  • Gross margin 66.0% → 69.3%

Trade setup

ATR% 6.1% $3.83 a day · 2×ATR $54.79
RS 23 / 99 vs the universe
Trend 2 / 8 trend template
Relative volume 2.5× vs 50-day average
Up/down volume 0.87 50 sessions
Implied move — no scheduled report
Trend template · 2 of 8
  • 150-day average above the 200-day: passes
  • At least 30% above the 52-week low: passes

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Oct 29, 2026
Results reaction Oct 29, 2026-7% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $211.1M +27% on FY2024
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $84.7M FY2021 · $126.7M FY2022 · $161.7M FY2023 · $165.2M FY2024 · $166.0M FY2025 · $211.1M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$51.1M
-$100M $0 FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$38.1M FY2021 · -$41.1M FY2022 · -$75.2M FY2023 · -$78.5M FY2024 · -$84.6M FY2025 · -$51.1M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$56.9M
-$100M $0 FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$14.6M FY2021 · -$30.0M FY2022 · -$55.0M FY2023 · -$96.4M FY2024 · -$64.6M FY2025 · -$56.9M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 69%
  • Net -24%
  • Free cash -27%
-100% 0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 62% · Net -45% · Free cash -17% FY2021 · Gross 67% · Net -32% · Free cash -24% FY2022 · Gross 66% · Net -47% · Free cash -34% FY2023 · Gross 65% · Net -48% · Free cash -58% FY2024 · Gross 66% · Net -51% · Free cash -39% FY2025 · Gross 69% · Net -24% · Free cash -27%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $171.9M net debt
  • Cash
  • Long-term debt
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $84.5M · Long-term debt $49.8M FY2021 · Cash $53.4M · Long-term debt $51.9M FY2022 · Cash $66.4M · Long-term debt $175.5M FY2023 · Cash $40.0M · Long-term debt $188.7M FY2024 · Cash $90.3M · Long-term debt $219.6M FY2025 · Cash $75.6M · Long-term debt $247.5M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 29.30m +24.6% since FY2020
29.30m 23.52m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 23.52m FY2021 · 24.08m FY2022 · 24.41m FY2023 · 26.09m FY2024 · 28.79m FY2025 · 29.30m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $84.7M $126.7M $161.7M $165.2M $166.0M $211.1M
Gross margin 62% 67% 66% 65% 66% 69%
Operating income -$27.9M -$25.1M -$39.7M -$65.0M -$50.0M -$39.0M
Net income -$38.1M -$41.1M -$75.2M -$78.5M -$84.6M -$51.1M
Net margin -45% -32% -47% -48% -51% -24%
Earnings per share -$1.63 -$1.72 -$3.08 -$3.07 -$3.00 -$1.72
Free cash flow -$14.6M -$30.0M -$55.0M -$96.4M -$64.6M -$56.9M
Free cash margin -17% -24% -34% -58% -39% -27%
Cash $84.5M $53.4M $66.4M $40.0M $90.3M $75.6M
Long-term debt $49.8M $51.9M $175.5M $188.7M $219.6M $247.5M
Shareholders' equity $75.0M $50.7M -$8.2M $18.4M $53.1M $23.5M
Shares outstanding 23.52m 24.08m 24.41m 26.09m 28.79m 29.30m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 7, 2026 Quarterly ↗ Jun 30, 2026 38d
May 8, 2026 Quarterly ↗ Mar 31, 2026 38d
Feb 27, 2026 Annual ↗ Dec 31, 2025 58d
Nov 7, 2025 Quarterly ↗ Sep 30, 2025 38d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 9, 2025 Quarterly ↗ Mar 31, 2025 39d
Feb 28, 2025 Annual ↗ Dec 31, 2024 59d
Nov 12, 2024 Quarterly ↗ Sep 30, 2024 43d
Aug 7, 2024 Quarterly ↗ Jun 30, 2024 38d
May 9, 2024 Quarterly ↗ Mar 31, 2024 39d
Mar 4, 2024 Annual ↗ Dec 31, 2023 64d
Nov 8, 2023 Quarterly ↗ Sep 30, 2023 39d

Current reports